Zalex-MD 5 Tablet contains Olanzapine 5 mg, an atypical antipsychotic agent primarily indicated for the treatment of schizophrenia and bipolar disorder. Olanzapine exerts its therapeutic effects by modulating the activity of various neurotransmitter receptors in the brain, including dopamine D2 and serotonin 5-HT2A receptors, thereby helping to restore the chemical balance associated with psychotic and mood disorders. Zalex-MD 5 is effective in managing symptoms such as hallucinations, delusions, disorganized thinking, mood swings, and agitation. It is also utilized as a maintenance treatment to prevent relapse in patients with schizophrenia and as part of combination therapy for acute manic or mixed episodes in bipolar disorder. The tablet is administered orally, with the dosage tailored according to the patient’s clinical condition and response to therapy. Common adverse effects may include sedation, weight gain, dry mouth, and metabolic changes; therefore, regular monitoring of metabolic parameters and patient status is recommended during treatment. Zalex-MD 5 should be prescribed and used under the supervision of a qualified healthcare professional, with caution advised in patients with a history of cardiovascular disease, diabetes, or seizures. It is contraindicated in individuals with known hypersensitivity to Olanzapine or any tablet components.